Metaphase-FISH (fluorescence in situ hybridization) was used detection of residual leukemic cells after treatment. 6,7,9,[11][12][13][14] 17 to detect cells with a chromosomal trisomy and/or transloIn ALL, chromosomal translocations such as t (9; Previously, we and others have shown the value of metaFor the optimal planning of treatment, it is clinically important phase-FISH in the follow-up of patients with CML 22,23 and to recognize as early as possible the patients who are at a high acute myeloid leukemia (AML). 24 In this study, 25 patients risk of relapse. The identification and quantification of with ALL were followed up using metaphase-FISH. residual leukemic cells in patients with ALL in remission reveals those who might be at risk of relapse and therefore require close clinical monitoring.
was detected at diagnosis and allows the study of up to 2000 or more mitotic cells in each sample with direct visualization and quantification of aberrant cells in the same time it takes Introduction to study 20 good metaphases by standard G-banding analysis. Previously, we and others have shown the value of metaFor the optimal planning of treatment, it is clinically important phase-FISH in the follow-up of patients with CML 22, 23 and to recognize as early as possible the patients who are at a high acute myeloid leukemia (AML). 24 In this study, 25 patients risk of relapse. The identification and quantification of with ALL were followed up using metaphase-FISH. residual leukemic cells in patients with ALL in remission reveals those who might be at risk of relapse and therefore require close clinical monitoring.
Materials and methods Conventional morphologic and standard immunocytochemical staining methods can detect 1-5% of residual leuPatients kemic cells in bone marrow. However, immunological marker analysis assays are able to detect leukemic cells at frequencies Twenty-five patients were identified who had achieved CR as low as 10 −4 when double or triple immunofluorescent stainand at diagnosis had a translocation, trisomy, or some other ing techniques are used.
1,2 PCR utilizing clonal-specific T cell structural chromosomal aberration suitable for follow-up with receptor (TCR) gamma or delta junctional regions and/or metaphase-FISH. Patients with only monosomies or small immunoglobulin heavy chain (IgH) gene rearrangements is a deletions were excluded from the study. Patients 9-12, 18, highly sensitive method for evaluating residual leukemic cells 19, and 25 were treated at the Children's Hospital, Helsinki in ALL patients in remission.
3-16 A positive result using the University Central Hospital, and the others at the Department PCR method indicated that relapse will occur in some of Medicine, Helsinki University Central Hospital. Patients 1-patients.
3-7,10,16 However, the clinical relevance of this tech-12 were treated with chemotherapy alone while patients 13-nique is yet to be defined as there are inconsistencies in the 25 received bone marrow transplantation (BMT) after an initial treatment with chemotherapy. All transplantations except one (patient 16) were allogeneic. Patients 18 and 19 received transplants from a matched unrelated donor, and the others geneic transplantations consisted of cyclophosphamide phases and 1-5% were anaphases. Only clear unbroken diploid metaphase-plates with no overlapping metaphases/nuclei (60 mg/kg/day) for 2 days and total body irradiation with 12 Gy in 6 fractions (lungs shielded to receive not more than were analyzed. Polyploid cells were excluded and all aberrations were checked by DAPI banding to confirm the mor-10 Gy). Prophylaxis for graft-versus-host disease consisted of cyclosporine for 9-12 months after BMT and four doses of phology and to identify the chromosomal groups. This technique allowed the study of 1000 mitotic cells in the same time methotrexate with or without methylprednisolone.
Bone marrow samples for the metaphase-FISH study were it takes to study 20 good metaphases by standard G-banding analysis. taken during clinical remission as indicated in Figure 1 (Table 1) . Standard cytogenetic studies were also performed at the end CISS studies, known as 'chromosome painting', were performed at diagnosis to confirm the chromosomal aberrations, of induction therapy and at relapse.
which were then followed up using chromosome 1, 4, 5, 6, 7, 8, 9, 10, 12 and 22 specific library probes (American Type Culture Collection, Rockville, MD, USA) according to Cremer
Metaphase-FISH et al. 26 The probes were labeled with biotin-14-dATP by nicktranslation (Nick Translation Kit; Bethesda Research LaboraStandard cytogenetic preparations were used for metaphase-FISH. Unstimulated BM cells were cultured for 12 h in the tories, Gaithersburg, MD, USA). The cells were pretreated with pepsin (0.01 mg/ml, Sigma, St Louis, MO, USA) followed presence of a high concentration of colcemid to increase the number of metaphases as described previously. 22 Each slide by dehydration in 70%, 90% and 96% ethanol. We used avidin-conjugated fluorescein isothiocyanate contained an average of 400 metaphases suitable for analysis following in situ hybridization. About 5% of the mitoses were (FITC; Vector Laboratories, Burlingame, CA, USA) to detect the hybridization signals. 27 The cells were counterstained early metaphases, 15% mid-metaphases, 80% late meta- with 4′,6-diamidino-2-phenylindole-dihydrochloride (DAPI, some 8 specific probe. For this metaphase, DAPI banding revealed a total of 47 chromosomes and confirmed an extra Sigma) and propidium iodide (Sigma).
The cells were mounted with Vectashield (Vector) antifadchromosome 8. ing solution and analyzed using a Zeiss fluorescence photomicroscope (Zeiss, Oberkochen, Germany) with Ziess filters 02 (FITC) and 09 (DAPI). In most patients, 1000-2000 metaDiscussion phases per sample were available for the analysis when two to four slides were scanned. The details of follow-up and sur-A total of 82 BM samples from 25 ALL patients in CR were followed up using metaphase-FISH. This technique is widely vival are presented in Figure 1 .
used in standard laboratories. Chromosome DNA-specific probe kits are now available from different commercial sources at reasonable prices. The technique described here Controls increased the number of metaphases and allowed rapid analysis of 1000-2000 metaphases within the time it takes to ana-BM aspirates from 10 normal BM donors were used as controls. At least 1000 metaphases were analyzed for each probe lyze 20 metaphases with G-banding. While analysis of 20 good-quality metaphases statistically rules out mosaicism at in each sample. For the analysis of t(9;22), t(8;9) and t(8;14), in situ hybridization was performed using chromosome 8, 9 approximately 14 × 10 −2 at a confidence limit of 0.95, 28 analysis of 2000 metaphases by metaphase-FISH rules out and 22 specific library probes. For the analysis of trisomies, probes specific for chromosome 7, 8 and 9 were used. The mosaicism present at 14 × 10 −4 at a confidence limit of 0.95 using the same statistical formula. However, the technique same criteria for interpretation were applied as above.
can be applied only to the follow-up of patients whose karyotypes have been analyzed at diagnosis and who had a chromosome trisomy or a translocation. For these aberrations the Results technique did not cause false positive results, but for monosomies metaphase-FISH (like karyotype analysis) yields a high We were able to analyze 1000-2000 cells in 64 samples (78%) and more than 500 cells in 18 samples (22%) (Figure 1) . false positive result (5-10%). Thus patients with monosomies as the only aberrations were excluded from the study. Our All patients treated with chemotherapy alone (Nos 1-12) had a normal karyotype at the end of induction therapy. Metadata demonstrate that regular follow-up with analyses of a large number of cells (Ͼ500) per sample can provide prognosphase-FISH was performed for half of them (Nos 1, 2, 4-6 and 9) and it revealed residual leukemic cells in patients 4 and 6. tic information (Figure 1 ). Abnormal cells are commonly found in patients with ALL, when between 500 and 2000 cells Later samples were free of the residual cells and the patients remained in CR. For the other half of the patients, it was not are analyzed. They were found in 52% of our patients. We found that low numbers of abnormal cells (0.05% to possible to get the lowest number of metaphases (500) required for the evaluation by metaphase-FISH due to the lack Ͻ1%) do not necessarily indicate an imminent relapse since they may disappear in subsequent samples. Instead, the presof material and the low mitotic index after induction therapy. For the transplanted patients, metaphase-FISH was performed ence of abnormal cells at frequencies higher than 1% at any sampling or an increasing level of abnormal cells that reached in the first 4 months after BMT for nine out of 13 patients and none of them showed residual leukemic cells. In the remain-1% or more in subsequent samples preceded relapse in all patients treated with chemotherapy alone or with BMT. The ing four patients (Nos 13, 15, 16 and 24), either no samples were available or the number of metaphases was insufficient time span before the first positive sample seems to be insignificant with regard to the outcome of relapse. The absence or to perform the analysis.
Abnormal cells were detected in 13 patients (52%) during presence of a low number of abnormal cells (0.05% to Ͻ1%) followed by their disappearance agreed with remission in all the follow-up. Seven of these patients had been treated with chemotherapy only (Nos 1, 2, 4, 6-8, 11), six with BMT (Nos patients treated with chemotherapy and in seven of 10 (70%) patients who received BMT. It has to be taken into account 15, 16, 21-24). An increase in the level of abnormal cells from Ͻ0.2% to 7% was seen in four patients (Nos 2, 7, 16 that the patients treated with chemotherapy alone were given maintenance treatment for 3 years after diagnosis. This may and 21), whereas a single occurrence of a high number of abnormal cells was detected in two patients (10% and 4%, have affected the behavior of the residual disease. Low number of abnormal cells may persist for a long time before they patients 1 and 15, respectively). These six patients suffered a relapse within 1-5 months. In the remaining seven patients disappear while the patient remains in remission. This was observed in patient 4, when abnormal cells were detected for (Nos 4, 6, 8, 11, 22-24), abnormal cells were detected at frequencies as low as 0.05% but never higher than 0.8% on any 2 years in several subsequent samples at frequencies of 0.05-0.8% before they disappeared. This may have been due to the occasion. One patient (No. 24) relapsed three times, whereas the other six (85.7%) remained in CR for 14-44 months from effect of maintenance treatment. PCR studies utilizing clono-specific TCR-gamma or -delta diagnosis. The latest samples from all these patients, except patient 8 from whom we did not have a second sample, conjunctional regions and/or IgH rearrangements have shown that the reappearance and/or an increasing/persisting level of PCR tain no abnormal cells (Figure 1) .
No abnormal cells were detected in any of the samples from positivity can indicate an impending relapse, whereas their disappearance correlates with CR in most patients.
6,7,13 the other 12 patients (Nos 3, 5, 9, 10, 12, 13, 14, [17] [18] [19] [20] 25) . Ten of them (83.3%) remained in CR for 16-40 months from Though the detection of residual disease by PCR during early chemotherapy treatment has been shown to be prognostically diagnosis. Patients 13 and 25 suffered a relapse after 9 and 12 months, respectively, from sampling ( Figure 1) . important, 11, 16, 29 this finding seems to have less clinical relevance early after BMT (3-6 months).
14 However, in our Our 10 controls showed no cells with t(9;22), t(8;9) or t(8;14). For trisomies 7, 8 and 9, only one metaphase (0.0001) study, the presence of abnormal cells calls for closer followup to monitor changes in their numbers, which may decline showed an additional painted chromosome with the chromo- 
